| Literature DB >> 34716785 |
Hanan Al Rayes1, Mansour Alazmi2, Suzan Attar3, Khaled Alderaan4, Mushabab Alghamdi5, Nayef Alghanim6, Ahmed Alhazmi7, Nadeer Alkhadhrawi8, Mohammad Almohideb9, Zeyad Alzahrani10, Mohamed Bedaiwi11, Hussein Halabi12.
Abstract
Psoriatic arthritis (PsA) is a highly heterogeneous disease with complex manifestations. Limited understanding of the disease and non-availability of local guidelines pose challenges in the management of PsA in Saudi Arabia. Therefore, this expert consensus is aimed to provide recommendations on the management of patients with PsA, including referral pathway, definition of remission and treat-to-target (T2T) approach. A Delphi technique of consensus development was used involving an expert panel comprised of 10 rheumatologists, one dermatologist and one family physician. Based on the review of available published evidence and the opinions of clinical experts, key recommendations were developed. A consensus was achieved in defining the following: management guideline adaptable for Saudi Arabia, most useful screening tool, laboratory investigations, imaging tests and criteria for referring suspected PsA patients to a rheumatologist. In addition, an agreement was achieved in defining the T2T strategy and remission for the clinical management of PsA. Overall, these recommendations provide an evidence-based framework for the management of PsA patients in Saudi Arabia.Entities:
Keywords: Early diagnosis; Expert consensus; Psoriatic arthritis; Referral pathway; Remission; Treat-to-target
Mesh:
Year: 2021 PMID: 34716785 DOI: 10.1007/s00296-021-05029-5
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631